Literature DB >> 22491194

Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

Nichola Z Lax1, Graham R Campbell, Amy K Reeve, Nobuhiko Ohno, Jessica Zambonin, Emma L Blakely, Robert W Taylor, Eduardo Bonilla, Kurenai Tanji, Salvatore DiMauro, Evelyn Jaros, Hans Lassmann, Doug M Turnbull, Don J Mahad.   

Abstract

OBJECTIVE: To explore myelin components and mitochondrial changes within the central nervous system in patients with well-characterized mitochondrial disorders due to nuclear DNA or mitochondrial DNA (mtDNA) mutations.
DESIGN: Immunohistochemical analysis, histochemical analysis, mtDNA sequencing, and real-time and long-range polymerase chain reaction were used to determine the pathogenicity of mtDNA deletions.
SETTING: Department of Clinical Pathology, Columbia University Medical Center, and Newcastle Brain Tissue Resource. PATIENTS: Seventeen patients with mitochondrial disorders and 7 controls were studied from August 1, 2009, to August 1, 2010. MAIN OUTCOME MEASURE: Regions of myelin-associated glycoprotein (MAG) loss.
RESULTS: Myelin-associated glycoprotein loss in Kearns-Sayre syndrome was associated with oligodendrocyte loss and nuclear translocation of apoptosis-inducing factor, whereas inflammation, neuronal loss, and axonal injury were minimal. In a Kearns-Sayre syndrome MAG loss region, high levels of mtDNA deletions together with cytochrome- c oxidase-deficient cells and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter and glia than axons) confirmed the pathogenicity of mtDNA deletions.
CONCLUSION: Primary mitochondrial respiratory chain defects affecting the white matter, and unrelated to inflammation, are associated with MAG loss and central nervous system demyelination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491194      PMCID: PMC3672633          DOI: 10.1001/archneurol.2011.2167

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  31 in total

1.  Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy.

Authors:  E Jaros; D J Mahad; G Hudson; D Birchall; S J Sawcer; P G Griffiths; J Sunter; D A S Compston; R H Perry; P F Chinnery
Journal:  Neurology       Date:  2007-07-10       Impact factor: 9.910

Review 2.  Myelin-associated glycoprotein (MAG): past, present and beyond.

Authors:  Richard H Quarles
Journal:  J Neurochem       Date:  2007-01-04       Impact factor: 5.372

3.  Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis.

Authors:  Xiaoping Qi; Alfred S Lewin; Liang Sun; William W Hauswirth; John Guy
Journal:  J Biol Chem       Date:  2006-08-18       Impact factor: 5.157

4.  Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome.

Authors:  C T Moraes; S DiMauro; M Zeviani; A Lombes; S Shanske; A F Miranda; H Nakase; E Bonilla; L C Werneck; S Servidei
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

Review 5.  Multiple system atrophy: an update.

Authors:  Nadia Stefanova; Philipp Bücke; Susanne Duerr; Gregor Karl Wenning
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

6.  Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation.

Authors:  Sarah E Lutz; Yongmei Zhao; Maria Gulinello; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

7.  A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.

Authors:  H E Gendelman; G H Pezeshkpour; N J Pressman; J S Wolinsky; R H Quarles; M J Dobersen; B D Trapp; C A Kitt; A Aksamit; R T Johnson
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

Review 8.  Neuropathology of mitochondrial diseases.

Authors:  Massimiliano Filosto; Giuliano Tomelleri; Paola Tonin; Mauro Scarpelli; Gaetano Vattemi; Nicolò Rizzuto; Alessandro Padovani; Alessandro Simonati
Journal:  Biosci Rep       Date:  2007-06       Impact factor: 3.840

9.  A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells.

Authors:  Kim J Krishnan; Andreas Bender; Robert W Taylor; Douglass M Turnbull
Journal:  Anal Biochem       Date:  2007-06-21       Impact factor: 3.365

10.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.

Authors:  Andreas Bender; Kim J Krishnan; Christopher M Morris; Geoffrey A Taylor; Amy K Reeve; Robert H Perry; Evelyn Jaros; Joshua S Hersheson; Joanne Betts; Thomas Klopstock; Robert W Taylor; Douglass M Turnbull
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

View more
  12 in total

1.  Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.

Authors:  Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

2.  Visual pathways evaluation in Kearns Sayre syndrome: a diffusion tensor imaging study.

Authors:  Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo
Journal:  Neuroradiology       Date:  2019-11-04       Impact factor: 2.804

3.  The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction.

Authors:  Felix Chan; Nichola Z Lax; Caroline Marie Voss; Blanca Irene Aldana; Shuna Whyte; Alistair Jenkins; Claire Nicholson; Sophie Nichols; Elizabeth Tilley; Zoe Powell; Helle S Waagepetersen; Ceri H Davies; Doug M Turnbull; Mark O Cunningham
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

4.  [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.

Authors:  Jelle van den Ameele; Young Hong; Roido Manavaki; Antonina Kouli; Heather Biggs; Zoe MacIntyre; Rita Horvath; Patrick Yu-Wai-Man; Evan Reid; Caroline H Williams-Gray; Ed Bullmore; Franklin Aigbirhio; Tim Fryer; Patrick Chinnery
Journal:  Neurology       Date:  2021-04-21       Impact factor: 9.910

5.  Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease.

Authors:  Nichola Z Lax; John Grady; Alex Laude; Felix Chan; Philippa D Hepplewhite; Grainne Gorman; Roger G Whittaker; Yi Ng; Mark O Cunningham; Doug M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-30       Impact factor: 8.090

6.  Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study.

Authors:  Nichola Zoe Lax; Philippa Denis Hepplewhite; Amy Katherine Reeve; Victoria Nesbitt; Robert McFarland; Evelyn Jaros; Robert William Taylor; Douglass Matthew Turnbull
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

7.  Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.

Authors:  Glen Lester Sequiera; Abhay Srivastava; Keshav Narayan Alagarsamy; Cheryl Rockman-Greenberg; Sanjiv Dhingra
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

Review 8.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

Review 9.  The genetics and pathology of mitochondrial disease.

Authors:  Charlotte L Alston; Mariana C Rocha; Nichola Z Lax; Doug M Turnbull; Robert W Taylor
Journal:  J Pathol       Date:  2016-11-02       Impact factor: 7.996

Review 10.  Review: Central nervous system involvement in mitochondrial disease.

Authors:  N Z Lax; G S Gorman; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2016-07-07       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.